These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 9167320)
1. Adequacy of hormone replacement therapy for osteoporosis prevention assessed by serum oestradiol measurement, and the degree of association with menopausal symptoms. Rodgers M; Miller JE Br J Gen Pract; 1997 Mar; 47(416):161-5. PubMed ID: 9167320 [TBL] [Abstract][Full Text] [Related]
2. Serum estradiol and gonadotropins level in postmenopausal women with or without hormone replacement. Limpaphayom K; Taechakraichana N; Kittinunvorakoon C J Med Assoc Thai; 1997 Mar; 80(3):147-52. PubMed ID: 9175381 [TBL] [Abstract][Full Text] [Related]
3. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes]. Brodowska A Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843 [TBL] [Abstract][Full Text] [Related]
4. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia. Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524 [TBL] [Abstract][Full Text] [Related]
5. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause]. Perrone G; Capri O; Borrello M; Galoppi P Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786 [TBL] [Abstract][Full Text] [Related]
6. An audit of oestradiol levels and implant frequency in women undergoing subcutaneous implant therapy. Buckler HM; Kalsi PK; Cantrill JA; Anderson DC Clin Endocrinol (Oxf); 1995 May; 42(5):445-50. PubMed ID: 7621560 [TBL] [Abstract][Full Text] [Related]
7. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone. Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347 [TBL] [Abstract][Full Text] [Related]
8. Estradiol and follicle-stimulating hormone levels in oophorectomized women applying percutaneous 17 beta-estradiol over the medial surface of the left arm. Taechakraichana N; Udomponglukkana S; Panyakhamlerd K; Leepipatpaibul S; Limpaphayom K J Med Assoc Thai; 1999 Feb; 82(2):115-20. PubMed ID: 10087717 [TBL] [Abstract][Full Text] [Related]
9. Circulating hormone levels in menopausal women receiving different hormone replacement therapy regimens. A comparison. Castelo-Branco C; Martínez de Osaba MJ; Fortuny A; Iglesias X; González-Merlo J J Reprod Med; 1995 Aug; 40(8):556-60. PubMed ID: 7473451 [TBL] [Abstract][Full Text] [Related]
10. Endogenous estrogen levels affect sexual function in elderly post-menopausal women. Modelska K; Litwack S; Ewing SK; Yaffe K Maturitas; 2004 Oct; 49(2):124-33. PubMed ID: 15474756 [TBL] [Abstract][Full Text] [Related]
11. The benefits of hormone replacement therapy in pre-menopausal women with oestrogen deficiency on haemodialysis. Matuszkiewicz-Rowiñska J; Skórzewska K; Radowicki S; Sokalski A; Przedlacki J; Niemczyk S; Włodarczyk D; Puka J; Switalski M Nephrol Dial Transplant; 1999 May; 14(5):1238-43. PubMed ID: 10344368 [TBL] [Abstract][Full Text] [Related]
12. Serum estradiol and follicle-stimulating hormone levels in Thai women post total abdominal hysterectomy and bilateral oophorectomy using oral 17 beta-estradiol. Bunyavejchevin S; Panthong C; Limpaphayom KK J Med Assoc Thai; 2002 Jan; 85(1):58-62. PubMed ID: 12075721 [TBL] [Abstract][Full Text] [Related]
13. Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal women. Reinhardt RA; Payne JB; Maze CA; Patil KD; Gallagher SJ; Mattson JS J Periodontol; 1999 Aug; 70(8):823-8. PubMed ID: 10476887 [TBL] [Abstract][Full Text] [Related]
14. Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women. Pae CU; Mandelli L; Han C; Ham BJ; Masand PS; Patkar AA; Steffens DC; De Ronchi D; Serretti A Neuro Endocrinol Lett; 2008 Aug; 29(4):500-6. PubMed ID: 18766158 [TBL] [Abstract][Full Text] [Related]
15. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. Weissberger AJ; Ho KK; Lazarus L J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the role of 17beta-oestradiol in bone metabolism in men: does the assay technique matter? The MINOS study. Szulc P; Claustrat B; Munoz F; Marchand F; Delmas PD Clin Endocrinol (Oxf); 2004 Oct; 61(4):447-57. PubMed ID: 15473877 [TBL] [Abstract][Full Text] [Related]
18. An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis. Ormarsdóttir S; Mallmin H; Naessén T; Petrén-Mallmin M; Broomé U; Hultcrantz R; Lööf L J Intern Med; 2004 Jul; 256(1):63-9. PubMed ID: 15189367 [TBL] [Abstract][Full Text] [Related]
19. Women's use of hormone replacement therapy for relief of menopausal symptoms, for prevention of osteoporosis, and after hysterectomy. Griffiths F; Convery B Br J Gen Pract; 1995 Jul; 45(396):355-8. PubMed ID: 7612339 [TBL] [Abstract][Full Text] [Related]
20. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women]. Lai A; Zhang J; Ding L Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]